Status:
UNKNOWN
The Method ISET (Insulation by Size of Epithelial Tumor Cells)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is, i) to assess the presence and the frequency of CTC in NSCLC patients undergoing surgery by using cytopathological analysis after their isolation by size (ISET method), and, i...
Detailed Description
Lung cancer is the most prevalent neoplasm and the major cause of tumor-related mortality worldwide. Despite recent advances in the management of resected lung cancers (i.e., the use of adjuvant thera...
Eligibility Criteria
Inclusion
- For the patients:
- patient having been operated for a strong suspicion or a suspicion of a malignant tumoral hurt corresponding to a primitive carcinoma not in small cell of the lung
- For the control subjects:
- Tabagical patients (between 10 and 30 packages years)
- unhurt of any malignant or mild tumoral pathology or patients that must benefit from a surgical operation for an extract of a hurt lung parenchymateuse for a not tumoral hurt
Exclusion
- Patient with histories of cancer or the other synchronous cancer
- Patient with carcinomas with small cells, bronchiolo-alveolar carcinomas, the other types of tumors (lymphomes, sarcomas, etc.).
- Patient with neoadditives treatments
- Patient according to treatments additives others than protocols codified (in particular, platinum navelbine or gemcitabine platinum) for stages II
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT00818558
Start Date
October 1 2008
End Date
October 1 2012
Last Update
December 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pr Paul HOFMAN
Nice, France